Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DUETACT® safely and effectively. See full prescribing information for DUETACT.DUETACT (pioglitazone and glimepiride) tablets for oral useInitial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
DUETACT is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulfonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulfonylurea alone [see Clinical Studies (14)]. Important Limitations of Use Pioglitazone exerts its antihyperglycemic effect only in the presence of endogenous insulin. DUETACT should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. Use caution in patients with liver disease [see Warnings and Precautions (5.5)].
- generic_name
- pioglitazone and glimepiride
- product_names
- pioglitazone and glimepiride
- ndc
- 64764-302, 64764-304, 64764-302-30, 64764-302-90, 64764-304-30, 64764-304-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en